{"title":"斯瓦特•古普塔","authors":"Swati Gupta","doi":"10.1287/c61bf895-f276-486a-948a-a7fae700b1d4","DOIUrl":null,"url":null,"abstract":"Before joining IAVI, Gupta was an executive director with Merck Vaccines, working on the development of innovative partnership models to address issues related to vaccine science and technology. In this role, she worked with stakeholders to accelerate Ebola vaccine development during the 2014-16 epidemic in West Africa. Previously, Gupta was in the department of epidemiology at Merck Research Laboratories, where she designed and led international prospective cohort studies of vaccine and infectious disease products in development. She also worked in HIV surveillance at the Communicable Disease Surveillance Centre in the U.K., and in the New York City Department of Health Bureau of Tuberculosis Control.","PeriodicalId":245599,"journal":{"name":"Authors group","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Swati Gupta\",\"authors\":\"Swati Gupta\",\"doi\":\"10.1287/c61bf895-f276-486a-948a-a7fae700b1d4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Before joining IAVI, Gupta was an executive director with Merck Vaccines, working on the development of innovative partnership models to address issues related to vaccine science and technology. In this role, she worked with stakeholders to accelerate Ebola vaccine development during the 2014-16 epidemic in West Africa. Previously, Gupta was in the department of epidemiology at Merck Research Laboratories, where she designed and led international prospective cohort studies of vaccine and infectious disease products in development. She also worked in HIV surveillance at the Communicable Disease Surveillance Centre in the U.K., and in the New York City Department of Health Bureau of Tuberculosis Control.\",\"PeriodicalId\":245599,\"journal\":{\"name\":\"Authors group\",\"volume\":\"14 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Authors group\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1287/c61bf895-f276-486a-948a-a7fae700b1d4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Authors group","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1287/c61bf895-f276-486a-948a-a7fae700b1d4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Before joining IAVI, Gupta was an executive director with Merck Vaccines, working on the development of innovative partnership models to address issues related to vaccine science and technology. In this role, she worked with stakeholders to accelerate Ebola vaccine development during the 2014-16 epidemic in West Africa. Previously, Gupta was in the department of epidemiology at Merck Research Laboratories, where she designed and led international prospective cohort studies of vaccine and infectious disease products in development. She also worked in HIV surveillance at the Communicable Disease Surveillance Centre in the U.K., and in the New York City Department of Health Bureau of Tuberculosis Control.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
